¼¼°èÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå : ÀûÀÀÁõº°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)
External Ventricular Drain Market by Indication (CSF Infection, Hydrocephalus, Intracranial Hypertension), End-User (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2025-2030
»óǰÄÚµå : 1589833
¸®¼­Ä¡»ç : 360iResearch Private Limited
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,939 £Ü 5,699,000
PDF, Excel & 1 Year Online Access (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 4,249 £Ü 6,147,000
PDF, Excel & 1 Year Online Access (2-5 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿Àϱâ¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 5,759 £Ü 8,332,000
PDF, Excel & 1 Year Online Access (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ Áö¿ª »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)
US $ 6,969 £Ü 10,083,000
PDF, Excel & 1 Year Online Access (Enterprise User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù. ¿Â¶óÀÎ Ç÷§Æû¿¡¼­ 1³â µ¿¾È º¸°í¼­¸¦ ¹«Á¦ÇÑÀ¸·Î ´Ù¿î·ÎµåÇÒ ¼ö ÀÖÀ¸¸ç, Á¤±âÀûÀ¸·Î ¾÷µ¥ÀÌÆ®µÇ´Â Á¤º¸µµ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. (¿¬ 3-4ȸ Á¤µµ ¾÷µ¥ÀÌÆ®)


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

³ú½Ç¿Ü¹è¾× ½ÃÀåÀº 2023³â¿¡ 57¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 62¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.39%·Î ¼ºÀåÇØ 2030³â¿¡´Â 95¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³ú½Ç¿Ü¹è¾×(EVD)Àº ³ú½Ç¿¡¼­ ³úô¼ö¾×(CSF)À» ¿ÜºÎ ¼öÁý ½Ã½ºÅÛÀ¸·Î ¹èÃâÇÏ¿© µÎ°³ ³»¾ÐÀÇ »ó½ÂÀ» °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. EVDÀÇ Çʿ伺Àº ¿Ü»ó¼º ³ú ¼Õ»ó, ¼öµÎÁõ, µÎ°³³» ÃâÇ÷ µîÀÇ Ä¡·á¿¡ À־ÀÇ ¿ªÇÒ¿¡ ±âÀÎÇÕ´Ï´Ù. EVD´Â ÁýÁß Ä¡·á ¹× ³ú¿Ü°ú ¼ö¼ú¿¡¼­ ÁÖ·Î »ç¿ëµÇ¸ç 3Â÷ ÀÇ·á±â°ü¿¡¼­ Áß¿äÇÑ ÀÀ¿ë ¹üÀ§°¡ µÇ°í ÀÖ½À´Ï´Ù. ½Å°æÁúȯÀÇ À¯º´·ü »ó½Â, ÀÇ·á±â¼úÀÇ Áøº¸, ÇコÄɾî ÁöÃâ Áõ°¡ µîÀÇ ¿µÇâÀ» ¹Þ¾Æ EVD´Â ²ÙÁØÈ÷ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ È®´ëµÇ´Â ½ÅÈï ½ÃÀåÀº ÁÖ¿ä ±â¾÷¿¡°Ô »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ µÉ °ÍÀÔ´Ï´Ù. ±×·¯³ª °¨¿° À§Çè, Àåºñ °ü·Ã ÇÕº´Áõ, ¼÷·ÃµÈ Àü¹®°¡ÀÇ ¼ö°¡ ÀûÀº µîÀÇ °úÁ¦°¡ ½ÃÀå È®´ëÀÇ Å« Á¦¾àÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀΰú ¾ö°ÝÇÑ ÀÇ·á ÄÄÇöóÀ̾𽺠±âÁØÀº ½ÃÀå »óȲ¿¡ º¹À⼺À» Á¦°øÇÕ´Ï´Ù. Çõ½ÅÀÇ ±âȸ´Â EVDÀÇ ¾ÈÀü¼º°ú È¿À²¼ºÀ» ³ôÀÌ´Â °ÍÀ̸ç, ´õ ³ªÀº ȯÀÚ ¸ð´ÏÅ͸µ°ú µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ ½º¸¶Æ® ±â¼úÀÇ ÅëÇÕÀÌ ±× °¡´É¼ºÀ» °¡Áö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ýü ÀûÇÕ¼º ¼ÒÀç ¹× °í±Þ ¹è¼ö ½Ã½ºÅÛ¿¡ ´ëÇÑ Á¶»çµµ ½ÃÀåÀ» ÀüÁø½Ãų ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº Àü¹® Áö½Ä°ú ÀÚ¿øÀ» °øÀ¯Çϱâ À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½Ê°ú °øµ¿ »ç¾÷¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ÀÇ·á Á¾»çÀÚ¸¦À§ÇÑ Áö¼ÓÀûÀÎ ±³À° ¹× ±³À° ÇÁ·Î±×·¥Àº Àåºñ Ãë±Þ ¹× ȯÀÚ ¾ÈÀü¿¡ °üÇÑ °úÁ¦¸¦ ¿ÏÈ­ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. EVD ½ÃÀåÀº °æÀïÀÌ ½ÉÇÏ°í ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀÌ Â÷º°È­ÀÇ ¿­¼è°¡ µË´Ï´Ù. ȯÀÚ ¾ÈÀü, Á¦Ç° ½Å·Ú¼º, »ç¿ë ÆíÀǼºÀ» ¼±È£ÇÏ´Â ±â¾÷ÀÌ ¼º°øÀ» °ÅµÑ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. KOL(Key Opinion Leader)¿Í °ü·ÃÇÏ¿© °Ç°­ °ü¸® Á¦°ø¾÷ü¿Í °­ÇÑ °ü°è¸¦ ±¸ÃàÇÏ´Â °ÍÀº ÃæÁ·µÇÁö ¾ÊÀº ¿ä±¸¸¦ ÆÄ¾ÇÇÏ°í ´õ ³ªÀº ÀÓ»ó °á°ú¸¦ ¾ò±â À§ÇØ Á¦Ç°À» Á¶Á¤ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 57¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 62¾ï ´Þ·¯
¿¹Ãø³â(2030) 95¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 7.39%

½ÃÀå ¿ªÇÐ: ½Å¼ÓÇÏ°Ô ÁøÈ­ÇÏ´Â ³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

³ú½Ç¿Ü¹è¾× ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

Porter's Five Forces: ³ú½Ç¿Ü¹è¾× ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼öÀÖ´Â ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³ú½Ç¿Ü¹è¾× ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. À» ¿¹ÃøÇÏ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ³ú½Ç¿Ü¹è¾× ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷Áö¼Å´×À» ¹à°Ô À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» ÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ³ú½Ç¿Ü¹è¾× ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³ú½Ç¿Ü¹è¾× ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐ·ùÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ³ú½Ç¿Ü¹è¾× ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

Á¦6Àå ³ú½Ç¿Ü¹è¾× ½ÃÀå : ÀûÀÀÁõº°

Á¦7Àå ³ú½Ç¿Ü¹è¾× ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå

Á¦11Àå °æÀï ±¸µµ

±â¾÷ ¸ñ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The External Ventricular Drain Market was valued at USD 5.78 billion in 2023, expected to reach USD 6.20 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 9.52 billion by 2030.

External Ventricular Drains (EVDs) are critical medical devices used to manage elevated intracranial pressure by draining cerebrospinal fluid (CSF) from the ventricles of the brain to an external collection system. The necessity of EVDs arises from their role in treating conditions such as traumatic brain injury, hydrocephalus, and intracranial hemorrhage. These devices are predominantly used in intensive care settings and neurosurgical procedures, highlighting their critical application scope in tertiary healthcare institutions. Market insights reveal a steady growth trajectory for EVDs, influenced by the rising prevalence of neurological disorders, advancements in medical technology, and increased healthcare spending. Emerging markets with expanding healthcare infrastructure offer new opportunities for key players. However, challenges such as the risk of infection, device-related complications, and a limited number of skilled professionals pose significant limitations to market expansion. Furthermore, regulatory approvals and stringent healthcare compliance standards add layers of complexity to the market landscape. Opportunities for innovation lie in enhancing the safety and efficiency of EVDs, potentially through the integration of smart technology for better patient monitoring and data analytics. Moreover, research into biocompatible materials and advanced drainage systems could propel the market forward. Companies should focus on strategic partnerships and collaborative ventures to leverage shared expertise and resources. Continuing education and training programs for healthcare professionals are essential to mitigate challenges related to device handling and patient safety. The nature of the EVD market is highly competitive, with constant innovation being key to differentiation. Firms that prioritize patient safety, product reliability, and ease of use will likely find success. Engaging with key opinion leaders and fostering strong relationships with healthcare providers will be crucial in identifying unmet needs and tailoring products for better clinical outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 5.78 billion
Estimated Year [2024] USD 6.20 billion
Forecast Year [2030] USD 9.52 billion
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving External Ventricular Drain Market

The External Ventricular Drain Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Porter's Five Forces: A Strategic Tool for Navigating the External Ventricular Drain Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the External Ventricular Drain Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the External Ventricular Drain Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the External Ventricular Drain Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the External Ventricular Drain Market

A detailed market share analysis in the External Ventricular Drain Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the External Ventricular Drain Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the External Ventricular Drain Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the External Ventricular Drain Market

A strategic analysis of the External Ventricular Drain Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the External Ventricular Drain Market, highlighting leading vendors and their innovative profiles. These include Argi Grup SaglIk Hiz. Tic. Ltd. Sti., B. Braun Melsungen AG, Fuji Systems Co., Ltd., Integra LifeSciences Corporation, IRRAS AB, Johnson & Johnson Services, Inc, KFF S. A., Medtronic PLC, MOLLER Medical GmbH, Neuromedex GmbH, Sophysa SA, and Spiegelberg GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the External Ventricular Drain Market to forecast the revenues and analyze trends in each of the following sub-markets:

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. External Ventricular Drain Market, by Indication

7. External Ventricular Drain Market, by End-User

8. Americas External Ventricular Drain Market

9. Asia-Pacific External Ventricular Drain Market

10. Europe, Middle East & Africa External Ventricular Drain Market

11. Competitive Landscape

Companies Mentioned

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â